Sort
40,608 grants matching “prostate cancer”
Tumor immune and glycan biomarkers for progressive prostate cancer
$552,871Jennifer D Wu · Northwestern University At Chicago · R01 · FY2022 · CA
A Multi-State Study of Cancer Treatment and Outcomes Among American Indians
$552,813Scott D Ramsey · Fred Hutchinson Cancer Research Center · R01 · FY2007 · CA
Nitric Oxide as a Modifier of Oxidative Stress
$552,789David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2019 · CA
RISK FACTORS FOR ADVANCED PROSTATE CANCER
$552,752University Of Southern California · R01 · FY2001 · CA
MBSR Symptom Cluster Trial for Breast Cancer Survivors
$552,723Cecile A Lengacher · University Of South Florida · R01 · FY2010 · CA
A Device for Physical Activity and Energy Expenditure
$552,720Minisun, Inc. · R44 · FY2003 · DK
Optoacoustic system for image-guided biopsy of prostate cancer
$552,654Alexander A Oraevsky · Fairway Medical Technologies, Inc. · R44 · FY2007 · CA
Mechanisms of Murine Tumor Eradication by Immunotherapy
$552,612Philip D Greenberg · University Of Washington · R01 · FY2010 · CA
Development of a novel biodegradable inorganic nanoparticle therapeutic for cancer
$552,591Jin Xie · University Of Georgia · R01 · FY2021 · CA
Molecular Targets for Cancer Detection and Treatment
$552,512William George Nelson · Johns Hopkins University · T32 · FY2014 · CA
THERAPEUTIC MANUFACTURING
$552,471Leland H Hartwell · Fred Hutchinson Cancer Research Center · P30 · FY2012 · CA
Deciphering the molecular mechanisms of histone code recognition by ATAD2/B
$552,452Karen Champagne Glass · University Of Vermont & St Agric College · R01 · FY2021 · GM
Characterizing Prostate Cancer By ex vivo MRS Signatures
$552,364Leo L Cheng · Massachusetts General Hospital · R01 · FY2008 · CA
Reactive Stroma and Tumor Associated Macrophages in Prostate Cancer Progression
$552,256Kenneth J. Pienta · University Of Michigan At Ann Arbor · U01 · FY2011 · CA
Reproductive and Developmental Toxicity of Dioxin
$552,137Richard E Peterson · University Of Wisconsin-Madison · R01 · FY2013 · ES
Control of Protein Translation in Cancer Pathogenesis
$551,829Pier Paolo Pandolfi · Sloan-Kettering Inst Can Research · U01 · FY2006 · CA
Commercialization of the Shutter-Speed Model for Dynamic MRI in Cancer Diagnosis
$551,816Ryan M Chamberlain · Imbio, Llc · R44 · FY2014 · CA
Congenic Mouse Medels of Melanoma for the Characterization of Tumor Immune Responses
$551,750Marcus W Bosenberg · Yale University · R01 · FY2017 · CA
Congenic Mouse Medels of Melanoma for the Characterization of Tumor Immune Responses
$551,750Marcus W Bosenberg · Yale University · R01 · FY2018 · CA
High Frame Rate 3-D Super Resolution Ultrasound Microvascular Imaging
$551,664Paul A Dayton · Univ Of North Carolina Chapel Hill · R01 · FY2017 · CA
Developing isoform-selective Hsp90 inhibitors for monotherapy and enhanced immunotherapy against lethal prostate cancer
$551,601Brian S J Blagg · University Of Notre Dame · R01 · FY2025 · CA
Serum Antibody Profiling with a Carbohydrate Microarray
$551,526Jeff Gildersleeve · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Statistical Methods for Genetic Epidemiology
$551,455Stanford University · R01 · FY2005 · CA
Differential TGF-Beta Signaling in Bone Microenviroment: Impact on Tumor Growth
$551,442Theresa A Guise · Indiana University Indianapolis · U01 · FY2011 · CA
Whitlockite nanoparticle-based immunotherapy for bone metastasis
$551,431Shiladitya Sengupta · Brigham And Women'S Hospital · R01 · FY2020 · CA